documents: FDA-2024-E-3572-0007

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-E-3572-0007 FDA FDA-2024-E-3572 Determination of Regulatory Review Period for Purposes of Patent Extension; TEVIMBRA Notice Determinations 2026-02-26T05:00:00Z 2026 2 2026-02-26T05:00:00Z 2026-04-28T03:59:59Z 2026-02-26T20:52:55Z 2026-03851 1 0 09000064b91deb48

Links from other tables